Option Care Health Announces Financial Results for the Second Quarter

NEXT STORY
Amarin Announces Plans to Maximize Blockbuster Potential of VASCEPA® (icosapent ethyl) in Europe
PREV STORY
CRISPR Technology Market to Grow by 20.91% in 2020, Accelerated by the Outbreak of COVID-19 – Industry Projections to 2030
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chiasma Reaches Agreement with FDA Under Special Protocol Assessment for a New Phase 3 Clinical Trial of Octreotide Capsules in Acromegaly

Chiasma plans to initiate enrollment in the new Phase 3 clinical trial – OPTIMAL ...

author_avatar
NASDAQ Market News

Generex Biotechnology Subsidiary Regentys Corporation Receives Approval of Japanese Patent for Extracellular Matrix Hydrogel (Regentys ECMH™)

author_avatar
NASDAQ Market News

Revolo Biotherapeutics Announces the Appointments of Marla S. Persky and Glen Giovannetti to its Board of Directors

author_avatar
NASDAQ Market News